SCIENTURE HOLDINGS, INC. Loss Contingency, Estimate of Possible Loss
SCIENTURE HOLDINGS, INC. (SCNX) had Loss Contingency, Estimate of Possible Loss of $200.00 thousand as of 2017-09-30, per its 10-Q filed 2017-11-07.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LossContingencyEstimateOfPossibleLoss · last filed 2017-11-07
- 2017-09-30: Loss Contingency, Estimate of Possible Loss $200.00K.
- 2017-06-30: Loss Contingency, Estimate of Possible Loss $200.00K.
| Period end | Loss Contingency, Estimate of Possible Loss |
|---|---|
| 2017-09-30 | $200.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $200.00K 10-Q · filed 2017-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |